ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.
AUTOR(ES)
Still, R A
RESUMO
Plasma homocysteine is emerging as an important risk factor for cardiovascular disease. Measurement in clinical laboratories is feasible by several techniques, including HPLC. Of particular importance is the potential for treatment by dietary modification and vitamin supplements, particularly folic acid. The outcome of vitamin intervention on cardiovascular events is awaited with interest. If the role of homocysteine is confirmed then it may rival cholesterol in importance as a cardiovascular risk factor.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=500636Documentos Relacionados
- Homocysteine and cardiovascular disease.
- ACP Broadsheet No 150. March 1997. Antenatal serological testing and prevention of haemolytic disease of the newborn.
- ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated?
- ACP Broadsheet No 127: April 1991. Measurement of catecholamines and their metabolites in urine.
- ACP Broadsheet No 142: November 1993. Measurement of carbon monoxide and cyanide in blood.